美国2009-2024年抢先肾移植等待名单后结局的种族与民族差异
该研究基于美国移植受者科学登记系统,纳入2009至2020年抢先等待名单的98863例成人首次肾移植候选者,随访至2024年。结果显示黑人和西班牙裔患者抢先 deceased 供肾移植率与白人相当,但亚裔、黑人和西班牙裔患者透析启动率更高且抢先活体供肾移植率更低。
要点
- 黑人和西班牙裔抢先 deceased 供肾移植率与白人相当,亚裔较低。
- 亚裔、黑人和西班牙裔抢先等待名单后透析启动率高于白人。
- 亚裔、黑人和西班牙裔抢先活体供肾移植率显著低于白人。
核心结论
- 黑人和西班牙裔抢先 deceased 供肾移植率改善并与白人相当,但亚裔、黑人和西班牙裔透析启动率更高且活体供肾移植率更低。
研究设计与样本
- 基于美国移植受者科学登记系统的前瞻性维护队列二次分析,纳入98863例2009年1月1日至2020年12月31日抢先等待名单的成人首次肾移植候选者,随访至2024年12月31日。
主要发现
- 2018-2020年,黑人和西班牙裔抢先 deceased 供肾移植率与白人相当(aSHR 0.99 [95%CI 0.92-1.07] 和 1.02 [95%CI 0.93-1.12]),亚裔较低(0.78 [95%CI 0.69-0.88])。
- 亚裔、黑人和西班牙裔透析启动率高于白人(aSHR 1.50 [95%CI 1.39-1.61]、1.41 [95%CI 1.34-1.49] 和 1.21 [95%CI 1.14-1.29])。
- 2018-2020年,亚裔、黑人和西班牙裔抢先活体供肾移植率低于白人(aSHR 0.49 [95%CI 0.44-0.54]、0.31 [95%CI 0.29-0.34] 和 0.61 [95%CI 0.56-0.66])。
关键数值与推荐
- 采用竞争风险模型估计调整后亚分布风险比(aSHR),数据按3年间隔分层(2009-2011、2012-2014、2015-2017、2018-2020)。
临床怎么用
- 针对抢先等待名单的亚裔、黑人和西班牙裔患者,应关注透析启动风险并努力改善活体供肾移植的可及性。
- 器官获取和移植网络等待时间积分及增加器官移植可及性指标可能有助于扩大抢先移植。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Among US preemptively waitlisted patients with CKD, deceased donor transplants increased for Black and Hispanic patients, comparable with White patients. Dialysis initiation was higher for waitlisted Asian, Black, and Hispanic patients compared with White patients, mirroring lower living donor transplants. Organ Procurement and Transplantation Network wait time credit and Increasing Organ Transplant Access metric could expand preemptive transplantation. BACKGROUND: Preemptive kidney transplantation (before dialysis initiation) is the optimal therapy for most transplant-eligible advanced patients with CKD. Although prior research has documented racial and ethnic disparities in preemptive referrals, less is known about distinct outcomes after preemptive waitlisting. This study examines the association between race and ethnicity and outcomes for preemptively waitlisted patients. METHODS: We conducted a secondary analysis of a prospectively maintained US cohort using data from the Scientific Registry of Transplant Recipients. The study population included 98,863 adult first-time kidney transplant candidates who were preemptively waitlisted from January 1, 2009, to December 31, 2020, and followed through December 31, 2024. The exposure of interest was race and ethnicity. The primary outcome was 3-year preemptive deceased donor kidney transplantation, living donor kidney transplantation, or dialysis initiation. We used competing risk models to estimate adjusted subdistribution hazard ratios (aSHRs). Data were stratified into 3-year intervals (2009–2011, 2012–2014, 2015–2017, and 2018–2020). RESULTS: Black and Hispanic patients received preemptive deceased donor kidney transplants as often as White patients (era 2018–2020, aSHRs [95% confidence interval (CI)]: 0.99 [95% CI, 0.92 to 1.07] and 1.02 [95% CI, 0.93 to 1.12], respectively), while Asian patients had lower rates (0.78 [95% CI, 0.69 to 0.88]). However, Asian, Black, and Hispanic patients were more likely to initiate dialysis (aSHRs: 1.50 [95% CI, 1.39 to 1.61]; 1.41 [95% CI, 1.34 to 1.49]; and 1.21 [95% CI, 1.14 to 1.29], respectively) and were less likely to receive preemptive living donor kidney transplants than White patients (era 2018–2020, aSHRs: 0.49 [95% CI, 0.44 to 0.54]; 0.31 [95% CI, 0.29 to 0.34]; and 0.61 [95% CI, 0.56 to 0.66], respectively). CONCLUSIONS: Among waitlisted patients with CKD in the United States between 2009 and 2020, rates of preemptive deceased donor kidney transplantation improved for Black and Hispanic patients and became comparable with White patients. However, Asian, Black, and Hispanic patients experienced higher rates of dialysis initiation and lower rates of preemptive living donor kidney transplantation.
引用
- Adeyemo S, Crews DC, Lentine KL, et al. Racial and Ethnic Disparities in Outcomes following Preemptive Kidney Transplant Waitlisting in the United States from 2009 to 2024. J Am Soc Nephrol. 2025. PMID: 40956672. doi:10.1681/ASN.0000000876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。